- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +24 more
- Locations
-
- Hospital Universitario Príncipe de Asturias Alcalá de Henares, Madrid, Spain
- Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain
- Hospital Universitario Reina Sofía Córdoba, Spain
Clinical trial condition
SARS-CoV-2
Explore clinical trials studying SARS-CoV-2. Study availability and eligibility vary by location and protocol.
171 public trials
3 recruiting studies
SARS-CoV-2 trial results
NCT06585241
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
- Locations
-
- CenExel Atlanta, Georgia, United States
- CenExel Decatur, Georgia, United States
- Velocity Clinical Research Baton Rouge, Louisiana, United States
- Velocity Clinical Research Gulfport, Mississippi, United States
NCT06458504
- Conditions
- HIV-1, SARS-CoV-2
- Locations
-
- Hematology and interne medicine department, Ambroise Paré hospital - APHP Boulogne-Billancourt, France
Not Yet Recruiting
Extended Remdesivir Infusion Combined With Nirmatrelvir/Ritonavir for Persistent SARS-CoV-2 Infection in Immunocompromised Patients
NCT06610643
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +11 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
Not Yet Recruiting
To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19
NCT04709328
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
- Locations
-
Not specified
NCT07720596
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
- Locations
-
- Department of Pharmacology, Third Faculty of Medicine, Charles University Prague, Czechia
NCT06743334
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
- Locations
-
- Pfizer Seoul, South Korea
Completed
Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data
NCT05876377
- Conditions
- COVID-19, Chronic Disease, Coronaviridae Infections, +16 more
- Locations
-
- Pfizer New York, United States
NCT04337424
- Conditions
- SARS-CoV-2
- Locations
-
- UCH Montpellier Montpellier, France
Completed
POC Performance Evaluation of LumiraDx SARS-CoV-2 Ag Ultra and SARS-CoV-2 & Flu A/B Tests.
NCT05728970
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
- Locations
-
- Paragon Rx Clinical, Inc Garden Grove, California, United States
- Torrance Clinical Research Institute Inc. Lomita, California, United States
- Hillcrest Medical Research, LLC DeLand, Florida, United States
- Hillcrest Medical Research DeLand, Florida, United States